The use of low doses of methotrexate during peri-cell infusion period may be a risk factor for acute kidney injury in patients subjected to hematopoietic stem cell transplantation
Ferraz, Fernanda Toledo Piza, Marra, Alexandre Rodrigues, Hamerschlak, Nelson, de Souza Durão Junior, MarcelinoVolume:
99
Journal:
Annals of Hematology
DOI:
10.1007/s00277-020-03928-4
Date:
March, 2020
File:
PDF, 279 KB
2020